Pulmonary hypertension with limited cutaneous scleroderma (CREST syndrome)

Netherlands Journal of Medicine

Volumn 57, Issue 6, 2000, Pages 229-232

  Berends, J C ^a   Dompeling, E C ^a   Van Der Star, J G ^a   Hoorntje, J C A ^a  

^a ISALA HOSPITAL   (Netherlands)

Author keywords

CREST syndrome; Monoclonal gammopathy; Pulmonary hypertension; Scleroderma

Indexed keywords

CALCIUM ANTAGONIST; CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ANTICOAGULATION; ARTICLE; CASE REPORT; DYSPNEA; EXERCISE TOLERANCE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG PARENCHYMA; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PLASMACYTOSIS; PROGNOSIS; PULMONARY HYPERTENSION; SCLERODERMA; SYNDROME CREST;

ANGIOGRAPHY; CREST SYNDROME; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FATAL OUTCOME; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033660092     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(00)00078-4     Document Type: Article

References (14)

1. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis
2. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis
3. Prevalence and clinical correlates of pulmonal arterial hypertension in progressive systemic sclerosis
4. Mortality and causes of death in a Swedish series of systemic sclerosis patients
5. Primary pulmonal hypertension: A rare but often fatal complication of CREST syndrome
6. Anticentromere antibodies (ACA): Clinical distribution and disease specificity
7. Anticentromere antibodies: Clinical correlates
8. Case records of the Massachusetts General Hospital
9. Acute and long term effect of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease
10. Nifidipine and prazosin in the management of pulmonary hypertension in CREST syndrome
11. Primary pulmonary hypertension: Natural history and the importance of thrombosis
12. Treatment of systemic sclerosis
13. Primary pulmonary hypertension
14. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease